A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fasting Condition
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The study was conducted as an open labeled, balanced, randomized, two-treatment, two-period,
two-sequence, single-dose, crossover, bioavailability study comparing acetaminophen extended
release gelcaps 650 mg of OHM Laboratories Inc. with Tylenol® Arthritis Pain caplets 650 mg
of McNeil Consumer & Specialty Pharmaceuticals, in healthy, adult, human, male subjects under
fasting condition.